Avidian Wealth Enterprises LLC Sells 102 Shares of CME Group Inc. $CME

Avidian Wealth Enterprises LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,823 shares of the financial services provider’s stock after selling 102 shares during the period. Avidian Wealth Enterprises LLC’s holdings in CME Group were worth $503,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Catalyst Capital Advisors LLC raised its holdings in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after acquiring an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. bought a new stake in CME Group during the first quarter worth about $367,000. Fulcrum Equity Management bought a new stake in CME Group during the first quarter worth about $258,000. AIA Group Ltd raised its holdings in CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 2,510 shares in the last quarter. Finally, Insight Inv LLC bought a new stake in CME Group during the first quarter worth about $2,712,000. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several research analyst reports. TD Cowen upped their price objective on CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a research note on Wednesday, October 8th. Jefferies Financial Group dropped their price objective on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Barclays dropped their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Oppenheimer upped their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Finally, UBS Group dropped their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $283.71.

Insider Transactions at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 over the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $267.81 on Thursday. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The stock’s 50 day moving average is $266.67 and its 200-day moving average is $271.45. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $96.51 billion, a price-to-earnings ratio of 25.93, a PEG ratio of 6.18 and a beta of 0.41.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the prior year, the business earned $2.68 earnings per share. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. Equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.